De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes

被引：0
|
作者：
Pierpaolo Falcetta
Francesca Nicolì
Fabrizia Citro
Annamaria Ciccarone
Monia Garofolo
Stefano Del Prato
Cristina Bianchi
机构：
[1] University of Pisa,Department of Clinical and Experimental Medicine
[2] University Hospital of Pisa,Department of Medicine
来源：
Acta Diabetologica | 2023年 / 60卷
关键词：
Insulin therapy; Basal-bolus; Glucagon-like peptide-1 receptor agonist; De-intensification;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 60
页数：7
相关论文
共 50 条
  • [1] De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes
    Falcetta, Pierpaolo
    Nicoli, Francesca
    Citro, Fabrizia
    Ciccarone, Annamaria
    Garofolo, Monia
    Del Prato, Stefano
    Bianchi, Cristina
    ACTA DIABETOLOGICA, 2023, 60 (01) : 53 - 60
  • [2] Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care
    Bonora, Benedetta Maria
    Rigato, Mauro
    Frison, Vera
    D'Ambrosio, Michele
    Tadiotto, Federica
    Lapolla, Annunziata
    Simioni, Natalino
    Paccagnella, Agostino
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 173
  • [3] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETOLOGIA, 2004, 47 : A265 - A266
  • [4] Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
    Bolli, Geremia B.
    Porcellati, Francesca
    Meier, Juris J.
    DIABETES CARE, 2020, 43 (10) : 2333 - 2335
  • [5] Basal insulin plus GLP-1 RA or SGLT2 inhibitor was noninferior to basal-bolus insulin intensification for HbA1c in T2DM
    Boggild, Miranda K.
    Cheung, Angela M.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) : JC106 - JC106
  • [6] De-Intensification from Basal-Bolus Insulin Therapy to Liraglutide in Type 2 Diabetes: Predictive Value of Mean Glycaemia during Fasting Test
    Pavlikova, Barbora
    Breburdova, Martina
    Krcma, Michal
    Kriz, Miroslav
    Kasparek, Jan
    Rusavy, Zdenek
    LIFE-BASEL, 2024, 14 (05):
  • [7] Personalized intensification of insulin therapy in type 2 diabetes - does a basal-bolus regimen suit all patients?
    Giugliano, D.
    Sieradzki, J.
    Stefanski, A.
    Gentilella, R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1425 - 1434
  • [8] Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: Results of the OSIRIS study
    Raccah, D.
    Haak, T. J.
    Huet, D.
    Monnier, L.
    Robertson, D.
    Labard, P.
    Soler, J.
    Penfornis, A.
    DIABETES & METABOLISM, 2012, 38 (06) : 507 - 514
  • [9] Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes
    Nauck, M. A.
    Hompesch, M.
    Filipczak, R.
    Le, T. D. T.
    Zdravkovic, M.
    Gumprecht, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (08) : 417 - 423
  • [10] Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure
    Joubert, M.
    Reznik, Y.
    DIABETES & METABOLISM, 2017, 43 : 2S34 - 2S38
12345